February 7, 2012
AVEO Pharmaceuticals, Inc. Announces Timing for Fourth Quarter and Year-End 2011 Financial Results, Webcast and Conference Call
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Feb. 7, 2012– AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that financial results for the company’s fourth quarter and year ended December 31, 2011 will be released before the market opens on Tuesday, February 14, 2012. The AVEO management team will host a conference call discussing the company’s financial results, recent developments and 2012 guidance on Tuesday, February 14, 2012 at 10:00 a.m. (ET). The call can be accessed by dialing 1-866-800-8652 (domestic) or 1-617-614-2705 (international) five minutes prior to the start of the call and providing the passcode 29955196. A replay of the call will be available approximately two hours after the completion of the call and can be accessed by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international), providing the passcode 99138406. The replay will be available for two weeks from the date of the live call.
The live, listen-only webcast of the conference call can be accessed by visiting the investors section of the AVEO website at http://investor.aveopharma.com. A replay of the webcast will be archived on the company’s website for two weeks following the call.
AVEO Pharmaceuticals (Nasdaq: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response Platform™ provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company’s website at www.aveopharma.com.
Source: AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc.
Monique Allaire, 617-299-5810
Caton Lovett, 910-232-7166